ClinicalTrials.Veeva

Menu

Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid

U

University of Cagliari

Status

Completed

Conditions

Lymph Node Metastases
Thyroid Cancer

Treatments

Procedure: Thyroidecomt and lymphectomy

Study type

Observational

Funder types

Other

Identifiers

NCT04274829
MICRO-PTC-LN

Details and patient eligibility

About

Papillary thyroid microcarcinoma (PTMC), defined as a tumor with larger diameter ≤ 1 cm, is considered a tumor with an indolent course and an excellent prognosis. Nevertheless, the incidence of lymph node metastasis in PTMC is not negligible, reaching up to 65% in some series. The aim of this study was to assess the incidence of lymph node metastasis in patients with PTMC and to evaluate predictive factors for lymph node metastasis.

Enrollment

300 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients with papillary microcarcinoma of the thyroid

Exclusion criteria

Patients with thyroid nodules > 1 cm; incomplete data

Trial design

300 participants in 1 patient group

PTMC
Description:
Patients with papillary microcarcinoma of the thyroid
Treatment:
Procedure: Thyroidecomt and lymphectomy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems